Two-point correlation function of density perturbations in a large void universe

We study the two-point correlation function of density perturbations in a spherically symmetric void universe model which does not employ the Copernican principle. First we solve perturbation equations in the inhomogeneous universe model and obtain density fluctuations by using a method of non-linear perturbation theory which was adopted in our previous paper. From the obtained solutions, we calculate the two-point correlation function and show that it has a local anisotropy at the off-center position differently from those in homogeneous and isotropic universes. This anisotropy is caused by the tidal force in the off-center region of the spherical void. Since no tidal force exists in homogeneous and isotropic universes, we may test the inhomogeneous universe by observing statistical distortion of the two-point galaxy correlation function.Comment: 16 pages, 3 figure

Carcinoembryonic Antigen (CEA) in Colorectal Cancer - Prognostic Significance of Portal Blood Level -

The prognostic significance of carcinoembryonic antigen (CEA) values in the drainage vein of the tumor (portal blood levels of CEA) of colorectal cancer patients were evaluated by examining the correlation with the peripheral blood levels of CEA and histopathologic findings of the tumor. 1) Portal blood levels of CEA were significantly increased by the operative procedure. Mean values of CEA in portal blood were higher than those in peripheral blood. Portal blood CEA was correlated with Dukes\u27 staging, and revealed higher positive rates than CEA in peripheral blood in each stage. Elevated CEA levels were noted in those who had cancer infiltration extending through the proper muscle layer. There was a close correlation between portal CEA and CEA content in cancerous tissue (ng/g, wet weight) (p<0.05), but no significant correlation between peripheral CEA level and cancerous tissue CEA (r = 0.372). The mean values of portal CEA in aneuploidy were significantly higher than those in diploidy. These findings indicate that circulating CEA in peripheral blood might be influenced by the metabolic process of CEA in the liver as well as cancer progression rather than CEA production of the tumor. 2) The 5 year survival rate of the patient\u27s group with a negative rate of portal CEA (93%) was far better than that with a positive rate (57%). This study suggested that the portal blood level of CEA in colorectal carcinoma may be very useful for assessment of the patient\u27s survival

2002ネン オヨビ 2003ネン カキ ナンキョクカイ ノ トウケイ 140ド セン ニ ソッタ プランクトン ノ ブンプ パターン

2002年及び2003年の南極海の夏季,東部インド洋区のウイルクスランド沖の東経140度線上において,白鳳丸及びタンガロアによる3回の調査航海によって行われたRMT-8(目合: 4.5mm, 開口面積: 8m3)ネット採集によって得られた標本に基づいて,大型動物プランクトン群集構造を調べた.クラスター解析の結果,大型動物プランクトン群集は,南極周極流の南縁(SB-ACC: Southern Boundary of the Antarctic Circumpolar Current)で大きく二つの群集に分けられた.すなわち,SB-ACCの北方では大型動物プランクトン群集は,Salpa thompsoni, Euphausia frigida及びThemisto gaudichaudiiなどのoceanic communityが卓越していた.一方,SB-ACCの南方ではEuphausia superba及びEuphausia crystallorophiasなど大陸寄りに主分布域をもつ動物プランクトンが卓越していた.SB-ACCは,南極海の上記の主要な大型動物プランクトン種の出現の差によって特徴付けられることが示唆された.Field surveys were conducted along 140°E in the Southern Ocean north of Terre Adelie during three cruises: the KH cruise by RV Hakuho Maru, and TC1 and TC2 cruises by RV Tangaroa during the austral summers of 2002 and 2003. Macrozooplankton were sampled using a Rectangular Midwater Trawl (RMT 8: mesh size: 4.5mm; effective mouth area: 8m2) along each transect. Macrozooplankton communities were separated by the Southern Boundary of the Antarctic Circumpolar Current (SB-ACC) based on cluster analysis. North of the SB-ACC, macrozooplankton assemblages comprised species of the northern oceanic community characterized by Salpa thompsoni, Euphausia frigida and Themisto gaudichaudii, while south of the SB-ACC, macrozooplankton assemblages were numerically dominated by Euphausia superba and/or Euphausia crystallorophias. It is suggested that the SB-ACC functions as the major biogeographic barrier to separate the macrozooplankton communities, and the contributions of macro- and meso-zooplankton to total zooplankton abundance varies seasonally as well as regionally in the Indian sector of the Southern Ocean crossing the SB-ACC

Lower In-Hospital Mortality With Beta-Blocker Use at Admission in Patients With Acute Decompensated Heart Failure

[Background] It remains unclear whether beta‐blocker use at hospital admission is associated with better in‐hospital outcomes in patients with acute decompensated heart failure. [Methods and Results] We evaluated the factors independently associated with beta‐blocker use at admission, and the effect of beta‐blocker use at admission on in‐hospital mortality in 3817 patients with acute decompensated heart failure enrolled in the Kyoto Congestive Heart Failure registry. There were 1512 patients (39.7%) receiving, and 2305 patients (60.3%) not receiving beta‐blockers at admission for the index acute decompensated heart failure hospitalization. Factors independently associated with beta‐blocker use at admission were previous heart failure hospitalization, history of myocardial infarction, atrial fibrillation, cardiomyopathy, and estimated glomerular filtration rate <30 mL/min per 1.73 m2. Factors independently associated with no beta‐blocker use were asthma, chronic obstructive pulmonary disease, lower body mass index, dementia, older age, and left ventricular ejection fraction <40%. Patients on beta‐blockers had significantly lower in‐hospital mortality rates (4.4% versus 7.6%, P<0.001). Even after adjusting for confounders, beta‐blocker use at admission remained significantly associated with lower in‐hospital mortality risk (odds ratio, 0.41; 95% CI, 0.27–0.60, P<0.001). Furthermore, beta‐blocker use at admission was significantly associated with both lower cardiovascular mortality risk and lower noncardiovascular mortality risk. The association of beta‐blocker use with lower in‐hospital mortality risk was relatively more prominent in patients receiving high dose beta‐blockers. The magnitude of the effect of beta‐blocker use was greater in patients with previous heart failure hospitalization than in patients without (P for interaction 0.04). [Conclusions] Beta‐blocker use at admission was associated with lower in‐hospital mortality in patients with acute decompensated heart failure

Association between Body Mass Index and Prognosis of Patients Hospitalized With Heart Failure

The prognostic implications of very low body mass index (BMI) values remain unclear in patients with acute decompensated heart failure (ADHF). This study aimed to investigate the prognostic impact of BMI classification based on the World Health Organization criteria in patients with ADHF. Among 3509 patients with ADHF and available BMI data at discharge in 19 participating hospitals in Japan between October 2014 and March 2016, the study population was divided into five groups; (1) Severely underweight: BMI < 16 kg/m², (2) Underweight: BMI ≥ 16 kg/m² and < 18.5 kg/m², (3) Normal weight: BMI ≥ 18.5 kg/m² and < 25 kg/m², (4) Overweight: BMI ≥ 25 kg/m² and < 30 kg/m² (5) Obese: BMI ≥ 30 kg/m². The primary outcome measure was all-cause death. The median follow-up duration was 471 days, with 96.4% follow up at 1-year. The cumulative 1-year incidence of all-cause death was higher in underweight groups, and lower in overweight groups (Severely underweight: 36.3%, Underweight: 23.9%, Normal weight: 14.4%, Overweight: 7.9%, and Obese: 9.0%, P < 0.001). After adjusting confounders, the excess mortality risk remained significant in the severely underweight group (HR, 2.32; 95%CI, 1.83–2.94; P < 0.001), and in the underweight group (HR, 1.31; 95%CI, 1.08–1.59; P = 0.005) relative to the normal weight group, while the lower mortality risk was no longer significant in the overweight group (HR, 0.82; 95%CI, 0.62–1.10; P = 0.18) and in the obese group (HR, 1.09; 95%CI, 0.65–1.85; P = 0.74). Very low BMI was associated with a higher risk for one-year mortality after discharge in patients with ADHF

Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry

[Background] No studies have explored the association between newly diagnosed infections after admission and clinical outcomes in patients with acute heart failure. We aimed to explore the factors associated with newly diagnosed infection after admission for acute heart failure, and its association with in‐hospital and post‐discharge clinical outcomes. [Methods and Results] Among 4056 patients enrolled in the Kyoto Congestive Heart Failure registry, 2399 patients without any obvious infectious disease upon admission were analyzed. The major in‐hospital and post‐discharge outcome measures were all‐cause deaths. There were 215 patients (9.0%) with newly diagnosed infections during hospitalization, and 2184 patients (91.0%) without infection during hospitalization. The factors independently associated with a newly diagnosed infection were age ≥80 years, acute coronary syndrome, non‐ambulatory status, hyponatremia, anemia, intubation, and patients who were not on loop diuretics as outpatients. The newly diagnosed infection group was associated with a higher incidence of in‐hospital mortality (16.3% and 3.2%, P<0.001) and excess adjusted risk of in‐hospital mortality (odds ratio, 6.07 [95% CI, 3.61–10.19], P<0.001) compared with the non‐infection group. The newly diagnosed infection group was also associated with a higher 1‐year incidence of post‐discharge mortality (19.3% in the newly diagnosed infection group and 13.6% in the non‐infection group, P<0.001) and excess adjusted risk of post‐discharge mortality (hazard ratio, 1.49 [95% CI, 1.08–2.07], P=0.02) compared with the non‐infection group. [Conclusions] Elderly patients with multiple comorbidities were associated with the development of newly diagnosed infections after admission for acute heart failure. Newly diagnosed infections after admission were associated with higher in‐hospital and post‐discharge mortality in patients with acute heart failure